Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Pandoraon Feb 07, 2023 7:46pm
106 Views
Post# 35273287

RE:RE:RE:new International Patent Application was filed by Ventripoin

RE:RE:RE:new International Patent Application was filed by Ventripoin
TheeRook wrote: VPT is behind, the in thing now is AI.  Since MSFT CHATGPT .  any company in AI Mentions AI and the stock rockets up.

Mayo Clinic research finds AI-enabled ECGs may identify patients at greater risk of stroke, cognitive decline

AI ECG Solution | Viatom Technology Cohttps://www.viatomtech.com › ai-ecg-platform
AI-ECG Platform combines artificial intelligence technology and ECG diagnosis to accurately identify heart beats and determine various types of arrhythmias .

Cardiomatics bags $3.2M for its ECG-reading AI 
 — The AI tool has analyzed more than 3 million hours of ECG signals commercially to date, per the startup, which says its software is being used ...



In case you have never noticed the term "AI" in the Ventripoint lead in story:

About Ventripoint Diagnostics Ltd.

Ventripoint has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary KBR technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada.

Possibly they are not as far behind as you suggest. Maybe you are just getting hyped a bit because of all the recent AI "ChatGPT" promotions? Everybody is now dancing to the tune.

 

<< Previous
Bullboard Posts
Next >>